NAMSA opens expanded preclinical lab near Minneapolis
02 Oct 2023
Acquisition
North American Science Associates (NAMSA) recently opened its expanded preclinical lab near Minneapolis.
It is “the biggest worldwide preclinical facility dedicated to medical medtech services,” NAMSA CEO Christophe Berthoux said in a promotional video by Medical Alley.
The facility — at 8945 Evergreen Boulevard in Coon Rapids, Minnesota — now has six cath labs and three operating rooms. The company said it added one more of each in the expansion to reduce wait times for procedures.
“We can do all sorts of different development studies for medical device manufacturers, all the way from very basic interventional procedures such as stent placement to highly complex studies” such as extracorporeal membrane oxygenation (ECMO), NAMSA SVP of Global Laboratory Operations Lisa Olson said in the video.
Toledo, Ohio-based NAMSA also expanded the facility’s lobby, break room, and locker space.
NAMSA announced the expansion in November 2021, saying it would add 55,000 ft² to the campus, which totaled 130,000 ft² at the time. The medtech contract research organization said wait times were as long as nine months at competitors.
Berthoux became NAMSA’s CEO in March 2021 after his private equity firm, ArchiMed, took a majority stake in the organization in September 2020. Since then, NAMSA has completed at least eight acquisitions, including American Preclinical Service, Syntactx and — most recently — The Clinical Research Institute.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.